We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.
The paradigm shift from batch to continuous manufacturing
After more than 50 years it is time for a paradigm shift.
We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.
With a special case study from the company simAbs on the continuous manufacturing process that consistently produces high-quality Drug Substance of monoclonal antibodies.
Download by clicking the thumbnail below.
For the most up to date news, please follow us on LinkedIn via the link below